The record-breaking temperatures, violent weather, crop failures, and massive waves of forced migration seem to have woken up the skeptics of climate change, says Phil Lempert from Supermarket Guru.
He talks about which metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on NAFLD. ...
Donald E. Fetterolf, MD, discusses the major advantage of amniotic membrane therapy: the ability of the allografts to attract stem cells to the region of the wound in order to rebuild damaged tissues.